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Abstract 
This article reports the opinions of an infection prevention panel of experts 
following a meeting convened during the 2012 World Congress of Vascular 
Access Congress (WoCoVa). The meeting reviewed some topics related to the 
use of peripheral venous catheters (PVCs) with a specific focus on infection 
prevention. The international panel agreed that lack of clinical evidence and 
scientific research regarding PVC management is a major cause of significant 
variances in practice. The panel has outlined a number of strategies that 
promote infection prevention during PVC use. However, no overall agreement 
was reached on all issues. Other reasons for non-resolution were mostly due to 
variance among countries due to differences in the organization of healthcare 
systems,  differences in availability of materials and difference in  national or 
supranational regulations.  
Key words Peripheral Catheterization, Catheter-Related Infections, Quality of 
Health Care 
 
Background 
Peripheral Venous Catheters (PVC) are one of the most common devices used 
in the delivery of medications and fluids to patients. Approximately 330 million 
short peripheral catheters are sold annually in the United States alone.1 In the 
EU, 46.7% (country range 30.6%–70.6%) of patients in acute care hospitals have 
one or more PVCs.2 Over previous decades, the use of PVCs has grown 
  
significantly in outpatient and alternative care settings. Intravenous catheters 
are the primary identifiable source of bloodstream infections (bacteremia and 
fungaemia).3 However, the magnitude of the proportion of infections associated 
with short peripheral versus central venous catheters remains unclear. 
Microbiologically confirmed PVC-related bloodstream infection accounts for 
0.4% of all healthcare-associated infections in the EU.2 Data on incidence of 
bloodstream infections (BSIs) associated with peripheral venous catheters are 
limited. Alternatively, it is uncommon to draw blood cultures through the PVC 
to confirm a potential PVC-related BSI. Moreover, contamination of the blood 
cultures with micro-organisms that colonize the PVC catheter or hub, is possible.  
McLaws and colleagues found a BSI rate for all peripheral lines of 0.2 (95%CI: 
0.0 - 0.5) per 1000 line-days in ICU.4 Although those BSI numbers seem low, they 
result in a significant number of affected patients. It was estimated in one study, 
which investigated Staphylococcus Aureus bacteremia’s, that there may be as 
many as 10,028 PVC-related bacteremia’s yearly in US adult hospitalized 
inpatients.5 
 
Despite the generalized use of PVCs, a range of procedures and a variety of 
products are available to support peripheral venous access management. As 
awareness around practice increases, the need for improving PVC care becomes 
clearer.6 Hadaway found in a recent integrative literature review on short PVC 
and infections that although much research is carried out on this topic, variables 
  
 
 
 
 
and research design issues leave numerous unaddressed issues and 
unanswered questions.1   
A panel with extensive professional experience was  convened to address two 
main goals: (1) to identify important issues in infection prevention and, (2) to 
agree on key strategies . 
 
Methods 
A roundtable meeting of 10 healthcare professionals from 8 different countries 
(Belgium, Denmark, Germany, Italy, Qatar, Sweden, United Kingdom, USA), was 
sponsored by BD Medical as part of 2nd World Congress on Vascular Access 
(WOCOVA) conference, June 2012 in Amsterdam. This was an independent 
meeting and BD Medical was not involved in either the content or outcome of 
the discussions. Three key areas associated with PVC management were 
proposed for discussion: insertion, care and maintenance. “Insertion” refers to 
the procedure of the (re)placement and characteristics of the peripheral 
cannula and the material for insertion.  “Care” is defined as all actions taken to 
keep the catheter in place and to protect the insertion site. “Maintenance” is 
defined as all measures taken to keep the catheter patent.  
Panelists then proposed their key strategies for improved patient outcomes 
around these three areas. The mentioned strategies therefore do not claim to 
reflect all infection prevention measures. 
 
  
Results 
1. PVC insertion  
What are the contributing factors in the choice for a certain type of catheter? 
The choice of PVC is often based on preferences. Many of the panel concurred 
regarding the relationship between different clinician groups and design 
preferences. These preferences, however, are not always based on scientific 
evidence. For instance, PVCs that include an access port on top of the catheter 
hub/adapter, also called ported catheters, are frequently used by 
anesthesiologists for the administration of anesthetic drugs during procedures. 
These ported catheters could, by design, contribute to a higher infection risk 
due to the lack of a closed intravenous system.   
Another important factor is the use of safety technology to prevent needle stick 
injuries incorporated into the design of the PVC. The move to PVCs with safety 
technology has been a challenge in some areas of the world. Panelists concurred 
that  design choice often comes down to cost, regardless of scientific evidence. 
Change will therefore be slow unless it reduces costs or is required by law. The 
panel acknowledged that the United States Needlestick Safety Legislation of 
2000 has driven an almost 100% adoption of safety IV catheters in acute care 
hospitals but not in alternative settings such as physician offices and clinics. The 
European sharps directive, May 2013, requires a risk assessment to determine 
the use of safety devices, although methods of implementation and 
enforcement are not yet clear.  
  
 
 
 
 
Agreement was not reached regarding the best practice for the choice of the 
cannula gauge size. The drivers that currently impact choice are: (1) clinical 
preference, (2) perception of gauge size requirements, (3) flow requirements, 
and (4) availability of electronic infusion equipment. 
 
What are the features of skin antisepsis and glove use? 
The panel concurred on the use of ChlorHexidine Gluconate (CHG) in 70% 
isopropanol for skin antiseptic agents prior to PVC insertion. Although it was 
mentioned that octenidine-hydrochloride/isopropanol was also used as an 
alternative antiseptic solution. The technique of application, most agreed that 
the best practice was to scrub back and forth and left to right, followed by the 
recommended drying time. Discordance among panel members was observed 
on the issue of the use of sterile gloves versus clean single use gloves during the 
insertion procedure. While all agreed that best practice is to always maintain a 
sterile procedure if possible, re-palpating the site after preparation is often 
observed. The panel concurred to always make every effort not to contaminate 
the site prior to PVC insertion. 
 
When should the PVC be replaced? 
The panel agreed that a distinction needed to be made between PVCs initially 
inserted using best practice, or not, such as in emergency situations. The 
participants all agree that any PVC inserted without adherence to the best 
  
infection prevention techniques should be resited as soon as possible. Many 
guidelines and standards recommend within 48 hours. No formal mechanism 
has been identified for a planned PVC replacement in routine care. Therefore, 
any transfer of the patient from one patient care area to another should include 
a discussion on the status of the PVC.  
 
What is the preferred content of a PVC insertion pack? 
Panel members agreed that the use of ready-made packs or kits that included 
cannulation equipment for the PVC insertion procedure were convenient. 
Components of such packs varied considerably within the experience of the 
panel. The advantages of using such a packs are that they conveniently place all 
insertion materials in one place. These packs also contribute to the patient’s 
comfort as facilitating an efficient insertion procedure. Moreover they can also 
encourage compliance with best practice. The panel agreed that the cost of 
these packs must be justified.  
 
2. PVC Care  
What are best practices for PVC dressing and stabilization to prevent 
infection? 
There was some disagreement between panelists on dressing technique. 
However, the group agreed that whatever materials are used, site visualization 
is critical to best practice management. Moreover, the group recommended 
  
 
 
 
 
strongly that loose dressings should be changed. The practice of planned site 
cleaning and dressing change remained unclear.  
The group reported a high level of variance around the methods used to stabilize 
a catheter such as (1) gauze and tape, (2) transparent membrane dressings, and 
(3) devices specifically designed to stabilize the PVC. Agreement was reached 
relating to the importance of stabilization of the catheter to prevent movement 
in the insertion site and subsequent infiltration/extravasation and phlebitis. 
 
What are key strategies in infection prevention with the use of needleless 
connectors? 
All panelists agreed that when needleless connectors are used, cleaning is 
paramount. However no strong agreement on the cleaning technique was 
reached. Two issues raised in this regard were: (1) the various connector designs 
and (2) the effectiveness of cleaning procedures. All agreed that the use of 
friction in the cleaning process and allowing adequate drying time were 
essential to a successful outcome. No agreement was formulated on adequate 
cleansing time. On the contrary the panelists agreed that 2% ChlorHexidine 
Gluconate in alcohol is preferred. Many countries do not have access to the 2% 
concentration of this solution and therefore it remains a deterrent to full scale 
adoption. Most of these agents have been brought to market for skin antisepsis, 
and little evidence exists supporting the efficacy of these agents on inanimate 
objects such as connectors. The panelists supported the new to market 
  
“disinfecting cap” which is designed to be placed on top of the needleless 
connector. In theory, this device protects the connector from contamination 
while not in use. Panelist agreed that cost of implementation could be an issue 
in most countries. 
 
3. PVC maintenance  
What are the best flushing and locking practices to ensure patency in PVCs? 
The group advocated normal saline as preferred locking solution for PVCs used 
for intermittent access.. However, one panelist reported the use of an obturator 
as an alternative to a locking solution. An obturator is a sterile stylet that blocks 
up the entire inner side of the catheter lumen to prevent thrombus formation 
when the infusion is discontinued. The panelists agreed that obturators should 
not be recommended because of the increased risk of contamination via de PVC 
hub and blood exposure.  
All panelists  supported the need to flush the PVC before and after medication 
administration.  With reported flushing volumes in the range of 5-10mL. The use 
of pre-filled flush syringes was recommended, but financial impact of (hospital-
wide) use could impact adoption. However, panelists  agreed that  pre-filled 
saline syringes should not be used for medication preparation with the rationale 
that there is an increased risk of contamination and potential medication errors 
due to inaccurate labeling.  
Key strategies on PVC insertion, care and maintenance are outlined in box 1. 
  
 
 
 
 
 
Conclusion 
The conclusion of this panel was that medical devices or equipment associated 
with vascular access can support infection prevention. However these products 
are not always available in all countries and cost is always an important factor 
when deciding to implement new materials. Products can support improvement 
if combined with education, both should go hand in hand. Regulatory 
authorities may also enhance change processes towards improved patient 
outcomes. Further studies, covering the PVC areas discussed above, should be 
encouraged to fill the current research gaps.  
In summary, the risk of Blood Stream Infections associated with the insertion 
and/or maintenance of PVC is limited at best. Therefore the expert panel 
encourages adoption of these interventions to minimize BSI risk in patients with 
a PVC.  
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Box 1 Key strategies agreed along the panel 
1. PVC Insertion 
Use ChlorHexidine in Alcohol preparation for skin antisepsis. 
Use a back and forth friction with the disinfectant and allow the preparation 
to dry completely prior to insertion of the device. 
Use sterile gloves if palpation of the site is necessary after prepping. 
Replace the PVC as soon as possible if infection prevention strategies were 
not employed during the insertion 
2. PVC care 
Maintain the PVC dressing dry and intact. 
Minimize catheter movement. 
Ensure that the insertion site is visible to allow for inspection. 
Needleless connectors cleaning with a 2% chorhexidine in alcohol is 
preferred. 
Clean needleless connectors using a scrubbing technique and allow to dry 
thoroughly prior to access. 
3. PVC  maintenance 
Use a normal saline lock when continuous infusion is no longer required. 
Perform a normal saline flush prior and after each medication 
administration. 
Use pre-filled flush syringes. 
  
Do not use pre-filled flush syringes for reconstitution or dilution of 
medications. 
 
 
